Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality? von Gafita, Andrei, Wang, Hui, Robertson, Andrew, Armstrong, Wesley R, Zaum, Raphael, Weber, Manuel, Yagubbayli, Farid, Kratochwil, Clemens, Grogan, Tristan R, Nguyen, Kathleen, Navarro, Fernando, Esfandiari, Rouzbeh, Rauscher, Isabel, Menze, Bjoern, Elashoff, David, Delpassand, Ebrahim S, Herrmann, Ken, Czernin, Johannes, Hofman, Michael S, Calais, Jeremie, Fendler, Wolfgang P, Eiber, Matthias

Volltext

Alpha‐emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor von Wahba, Andrew, Delpassand, Ebrahim S., Nunez, Rodolfo, Esfandiari, Rouzbeh, Venkatramani, Rajkumar

Volltext

Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber von Delpassand, Ebrahim S., Rohren, Eric M., Weber, Wolfgang A., Czernin, Johannes

Volltext

Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial von Delpassand, Ebrahim S, Tworowska, Izabela, Esfandiari, Rouzbeh, Torgue, Julien, Hurt, Jason, Shafie, Afshin, Núñez, Rodolfo

Volltext

Targeted α -Emitter Therapy with 212 Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial von Delpassand, Ebrahim S, Tworowska, Izabela, Esfandiari, Rouzbeh, Torgue, Julien, Hurt, Jason, Shafie, Afshin, Núñez, Rodolfo

Volltext

Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer von BRESLIN, Tara M, COHEN, Lisa, ROSS, Merrick I, SINGLETARY, S. Eva, BUZDAR, Aman U, HORLOBAGYI, Gabriel N, HUNT, Kelly K, SAHIN, Aysegul, FLEMING, Jason B, KUERER, Henry M, NEWMAN, Lisa A, DELPASSAND, Ebrahim S, HOUSE, Rosalyn, AMES, Frederick C, FEIG, Barry W

Volltext

Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States von Delpassand, Ebrahim S, Yazdi, Soheil M, Ghantoji, Shashank, Nakasato, Antonio, Strickland, Corinne, Nunez, Rodolfo, Shafie, Afshin, Cork, Susan, Byrne, Clare, Tang, Jackson, Patel, Jeetvan

Volltext

Effectiveness and Safety of Retreatment with 177 Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States von Delpassand, Ebrahim S, Yazdi, Soheil M, Ghantoji, Shashank, Nakasato, Antonio, Strickland, Corinne, Nunez, Rodolfo, Shafie, Afshin, Cork, Susan, Byrne, Clare, Tang, Jackson, Patel, Jeetvan

Volltext

Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children von Foster, Jennifer H., Sher, Andrew, Seghers, Victor, Poston, Jay, Wells, Donald, Delpassand, Ebrahim S., Potter, Samara, Mahajan, Priya, Venkatramani, Rajkumar

Volltext

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment von Hamiditabar, Mohammadali, Ali, Muzammil, Roys, Joseph, Wolin, Edward M, OʼDorisio, Thomas M, Ranganathan, David, Tworowska, Izabela, Strosberg, Jonathan R, Delpassand, Ebrahim S

Volltext

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [ 64 Cu]Cu-DOTA-TOC von Vahidfar, Nasim, Farzanehfar, Saeed, Abbasi, Mehrshad, Mirzaei, Siroos, Delpassand, Ebrahim S, Abbaspour, Farzad, Salehi, Yalda, Biersack, Hans Jürgen, Ahmadzadehfar, Hojjat

Volltext

Cardiac Toxicity in a Patient Receiving Peptide Receptor Radionuclide Therapy von Hendifar, Andrew E, Delpassand, Ebrahim S, Kittleson, Michelle M, Tuli, Richard

Volltext

Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma von Chiu, Alice C, Delpassand, Ebrahim S, Sherman, Steven I

Volltext

Tumor Sink Effect in 68 Ga-PSMA-11 PET: Myth or Reality? von Gafita, Andrei, Wang, Hui, Robertson, Andrew, Armstrong, Wesley R, Zaum, Raphael, Weber, Manuel, Yagubbayli, Farid, Kratochwil, Clemens, Grogan, Tristan R, Nguyen, Kathleen, Navarro, Fernando, Esfandiari, Rouzbeh, Rauscher, Isabel, Menze, Bjoern, Elashoff, David, Delpassand, Ebrahim S, Herrmann, Ken, Czernin, Johannes, Hofman, Michael S, Calais, Jeremie, Fendler, Wolfgang P, Eiber, Matthias

Volltext

Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model von Stallons, Tania A. Rozgaja, Saidi, Amal, Tworowska, Izabela, Delpassand, Ebrahim S., Torgue, Julien J.

Volltext

Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study von Gafita, Andrei, Fendler, Wolfgang P., Hui, Wang, Sandhu, Shahneen, Weber, Manuel, Esfandiari, Rouzbeh, Calais, Jeremie, Rauscher, Isabel, Rathke, Hendrik, Tauber, Robert, Delpassand, Ebrahim S., Weber, Wolfgang A., Herrmann, Ken, Czernin, Johannes, Eiber, Matthias, Hofman, Michael S.

Volltext

Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors von Hamiditabar, Mohammadali, Ali, Muzammil, Bolek, Luke, Vahdati, Gelareh, Tworowska, Izabela, Delpassand, Ebrahim S

Volltext

Peptide receptor radionuclide therapy in the United States von Bhargava, Peeyush, Delpassand, Ebrahim S

Volltext

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial von Tu, Shi-Ming, Millikan, Randall E, Mengistu, Bayabel, Delpassand, Ebrahim S, Amato, Robert J, Pagliaro, Lance C, Daliani, Danai, Papandreou, Christos N, Smith, Terry L, Kim, Jeri, Podoloff, Donald A, Logothetis, Christopher J

Volltext

Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine von Bhargava, Peeyush, He, Guocheng, Samarghandi, Amin, Delpassand, Ebrahim S

Volltext